- About the Platform: DLT (Decoding Longevity Trends) is a specialist intelligence platform that helps pharma, investors, and biotech teams identify longevity opportunities across 700+ longevity biotech companies, 3,100+ drug assets, and 14 longevity biotech domains, with a built-in AI copilot for live querying.
- Industry: Longevity biotech and life sciences intelligence (SaaS)
- Services we offered: Fractional CTO leadership, AI platform re-architecture (lifting model accuracy from around 60% to over 90%), full-stack engineering alongside our in-house team.
- Partner Since: 2025
Phil Newman, CEO & Founder